Association Analysis of Insulin Resistance and Osteoporosis Risk in Chinese Patients with T2DM

被引:20
|
作者
Wang, Xinshui [1 ]
Jiang, Lijuan [2 ]
Shao, Xiaonan [3 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Endocrinol, Changzhou 213003, Peoples R China
[2] Soochow Univ, Affiliated Hosp 3, Dept Clin Lab, Changzhou 213003, Peoples R China
[3] Soochow Univ, Affiliated Hosp 3, Dept Nucl Med, Changzhou 213003, Peoples R China
关键词
type 2 diabetes mellitus; insulin resistance; osteoporosis; bone mineral density; homeostasis model assessment for insulin resistance; HOMEOSTASIS MODEL ASSESSMENT; TYPE-2; DIABETES-MELLITUS; BETA-CELL FUNCTION; POSTMENOPAUSAL WOMEN; METABOLIC SYNDROME; BONE; PREVENTION; ADIPOSITY; FRACTURE;
D O I
10.2147/TCRM.S328510
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: To explore the relationship between insulin resistance and osteoporosis risk in Chinese patients with type 2 diabetes mellitus (T2DM). Methods: A total of 234 T2DM patients were retrospectively analyzed, and their lumbar bone mineral density (BMD) and insulin resistance using C-peptide-based homeostasis model of insulin resistance [HOMA-IR (CP)] were assessed. Univariate and multivariable logistic regression methods were used to evaluate the association between HOMA-IR (CP) and osteoporosis, and subgroup analysis was performed on female and male patients. Results: After fully adjusting the covariates, the association between HOMA-IR (CP) and osteoporosis was only significant in female patients (P = 0.022); the interaction effect with gender was significant (P for interaction <0.05). Curve fitting showed that the relationship between HOMA-IR (CP) and osteoporosis in women was nonlinear. When HOMA-IR (CP) is <4.00, its effect on osteoporosis was not significant (P = 0.474); when HOMA-IR (CP) is >4.00, the risk of osteoporosis increased significantly, with OR = 26.88 (95% CI: 2.75- 262.69, P = 0.005). The relationship between insulin resistance and osteoporosis risk in T2DM patients is significantly affected by gender. Conclusion: The higher the degree of insulin resistance in female patients, the greater the risk of osteoporosis, but the two are not linearly associated.
引用
收藏
页码:909 / 916
页数:8
相关论文
共 50 条
  • [31] Defining genetic risk of T2DM
    Claire Greenhill
    Nature Reviews Endocrinology, 2019, 15 : 438 - 438
  • [32] Insulin plus metformin for T2DM—are there benefits?
    Clifford J. Bailey
    Nature Reviews Endocrinology, 2012, 8 : 449 - 450
  • [33] Treating T2DM with Early Insulin Therapy
    Agarwal, Amit
    Norton, Pamela
    McNamara, John
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (09): : 49 - +
  • [34] Defining genetic risk of T2DM
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (08) : 438 - 438
  • [35] Islet cell function is as interesting as insulin resistance for T2DM treatment options
    Goeke, Burkhard
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 : 1 - 1
  • [36] Dietary factors in the risk of T2DM
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (10) : 537 - 537
  • [37] Statin dose and T2DM risk
    Rosanne Diaz
    Nature Reviews Endocrinology, 2011, 7 (9) : 499 - 499
  • [38] Insulin and Fiber Type in the Offspring of T2DM Subjects with Resistance Training and Detraining
    Schofield, Katherine L.
    Rehrer, Nancy J.
    Perry, Tracy L.
    Ross, Angus
    Andersen, Jesper L.
    Osborne, Hamish
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2012, 44 (12): : 2331 - 2339
  • [39] Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM
    Colosimo, Santo
    Mitra, Sandip Kumar
    Chaudhury, Tirthankar
    Marchesini, Giulio
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 206
  • [40] Relation of fat cell size to insulin resistance and regional adiposity in T2DM
    Azuma, K
    Kelley, DE
    Heilbronn, LK
    Albu, JB
    Smith, SR
    Ravussin, E
    DIABETES, 2005, 54 : A344 - A344